Towards a multidimensional patient reported outcome measures assessment: Development and validation of a questionnaire for patients with ankylosing spondylitis/spondyloarthritis

Joint Bone Spine

Volumn 77, Issue 6, 2010, Pages 575-581

  El Miedany, Yasser ^a,c   El Gaafary, Maha ^b   Youssef, Sally ^a,c   Palmer, Deborah ^c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c DARENT VALLEY HOSPITAL   (United Kingdom)

Author keywords

Ankylosing spondylitis; Outcome measures; Spondyloarthritis

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; ENTHESITIS; FALLING; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICIAN; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; RIGIDITY; SPINAL PAIN; SPONDYLOARTHROPATHY; VALIDITY;

ACTIVITIES OF DAILY LIVING; ADULT; CERVICAL VERTEBRAE; DIAGNOSTIC SELF EVALUATION; DISABILITY EVALUATION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PAIN; PATIENT PARTICIPATION; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78649909068     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.02.017     Document Type: Article

References (42)

1. Sieper J., Braun J., Rudwaleit M., et al. Ankylosing spondylitis: an over overview. Ann Rheum Dis 2002, 61. iii8-18.
2. Boonen A., de Vet H., van der Heijde D., et al. Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review. J Rheumatol 2001, 28:1056-1062.
3. Ward M.M. Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 1999, 12:247-255.
4. Greenhalgh J., Long A.F., Flynn R. the use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory?. Soc Sci Med 2005, 60:833-843.
5. Guyatt G.H., Feeny D.H., Patrick D.L. Measuring health related quality of life. Ann Int Med 1993, 118:622-629.
6. Stucki G. International Classification of Functioning Disability and Health (ICF): a promising framework and classification for rehabilitation medicine. Am J Phys Med Rehabil 2005, 84:733-740.
7. Stucki G., Boonen A., Tugwell P., et al. The World Health Organization International classification of functioning disability and health 2001, World Health Organization, Geneva.
8. Boonen A, Braun J, van der Horst-Bruinsma I, Huang F, Maksymowych W, Kostanjsek N. et al. The ASAS/WHO ICF Core Set for ankylosing spondylitis: how to classify the impact of AS on functioning and health. Ann Rheum Dis 2009; doi:10.1136/ard.2008.104117.
9. Schwarzkopf S.R., Ewert T., Dreinhofer K.E., et al. Towards an ICF Core Set for chronic musculoskeletal conditions: commonalities across ICF Core Sets for osteoarthritis, rheumatoid arthritis, osteoporosis, low back pain and chronic widespread pain. Clin Rheumatol 2008, 27:1355-1361.
10. Bellamy N., Kaloni S., Pope J., et al. Quantitative rheumatology: a survey of outcome measurement procedures in routine rheumatology outpatient practice in Canada. J Rheumatol 1998, 25:852-858.
11. Wolfe F., Pincus T. Listening to the patient. A practical guide to self-report questionnaires in clinical care. Arthritis Rheum 1999, 42:1797-1808.
12. van der Heijde D., Calin A., Dougados M., et al. Selection of instruments in the core set for DC-ART SMARD, physical therapy and clinical record keeping in ankylosing spondylitis: progress report of the ASAS working Group. J Rheumatol 1999, 26:951-954.
13. Fitzpatrick R. The measurement of health status and quality of life in rheumatological disorders. Ballieres Clin Rheumatol 1993, 7:297-317.
14. van der Linden S.J., Walkenburg H.A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis-a proposal for modification of the New York criteria. Arthritis Rheum 1984, 27:361-368.
15. Amor B., Dougados M., Mijiyawa M. Criteria of the classification of spondylarthropathies. Rev Rhum (Fr) 1990, 57:85-89.
16. El Miedany Y., El Gaafary M., El Aroussy N., et al. Patient reported outcomes in ankylosing spondylitis: development and validation of a combined questionnaire for functional impairment and quality of life assessment. Ann Rheum Dis 2009, 68:125.
17. Callahan L.F., Brooks R.H., Pincus T. Further analysis of learned helplessness in rheumatoid arthritis using a 'Rheumatology Attitudes Index'. J Rheumatol 1988, 15:418-426.
18. El Miedany Y., El Gaafary M., Youssef S., et al. Validity of the developed arabic multidimensional Health Assessment Questionnaire for use in standard clinical care of patients with rheumatic diseases. Int J Rheum Dis 2008, 11:224-236.
19. El Miedany Y., El Gaafary M., Palmer D. Answering the difficult question: how to identify rheumatoid arthritis patients at increased risk of cardiovascular disease in the standard practice. Ann Rheum Dis 2009, 68:78.
20. Heuft-Dorenbosch L., Spoorengerg A., van Tubergen A., et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003, 62:127-132.
21. Mackay K., Mack C., Brophy S., et al. The Bath Ankylosing Spondylitis Radiology Index (BASRI) A new validated approach to disease assessment. Arthritis Rheum 1998, 41:2263-2270.
22. van der Heijde D., Dougados M., Davis J., et al. Assessment in ankylosing spondylitis international working group/spondylitis association of America recommendation for conducting clinical trials in ankylosing spondylitis. Arthritis Rheum 2005, 52:386-394.
23. van der Heijde D., Calin A., Dougados M., et al. Selection of instruments in the core set for DC-ART SMARD, physical therapy and clinical record keeping in ankylosing spondylitis: progress report of the ASAS working Group. J Rheumatol 1999, 26. 951-4.16.
24. Doward L.C., Spoorenberg A., Cook S.A., et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003, 62:20-26.
25. Van der Heijde D., Landewe R., Rudwaleit M., et al. Performance of the ankylosing spondylitis activity score in 1250 ankylosing spondylitis patients treated with adalimumab. Ann Rheum Dis 2009, 68:126.
26. Fitzpatrick R., Davey C., Buxton M.J., et al. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998, 2:1-74.
27. Salaffi F., Carotti M., Gasparini S., et al. The health related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009, 7:25-37.
28. Pincus T., Bergman M.J., Yazici Y., et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 2008, 47(3):345-349.
29. Pincus T., Yazici Y., Bergman M., et al. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on multidimensional health assessment questionnaire (MDAHQ). Best Pract Res Clin Rheumatol 2007, 21:789-804.
30. Braun J., McHugh N., Singh A., et al. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50mg once weekly and 25mg twice weekly. Rheumatology (Oxford) 2007, 46:999-1004.
31. Pincus T., Sokka T., Kautiainenstudy H. Further development of a Physical Function Scale on a multidimensional Health Assessment Questionnaire for standard care of patients with rheumatic diseases. J Rheumatol 2005, 32:1432-1439.
32. El Miedany Y., Palmer D. Can standard rheumatology practice be patient based?. BJN 2008, 17:673-675.
33. Xu M., Lin Z., Liao Z., et al. To verify the clinical value of the new ankylosing spondylitis disease activity score (ASDAS) in Chinese ankylosing spondylitis and UspA patients. Arthritis Rheum 2009, 60:S202.
34. Chenglong H., Robinson D., Hackett M., et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006, 33:2167-2172.
35. Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2009; DOI:10.1136/ard.2009.113696.
36. Alaranta H., Luoto S., Konttinen Y.T. Traumatic spinal cord injury as a complication to ankylosing spondylitis An extended report. Clin Exp Rheumatol 2002, 20:66-68.
37. Cooper C., Carbone L., Michet C.J., et al. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 1994, 21:1877-1882.
38. Olerud C., Frost A., Bring J. Spinal fractures in patients with ankylosing spondylitis. Eur Spine J 1996, 5:51-55.
39. Heiberg M.S., Nordvag B.Y., Mikklesen K. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study. Arthritis Rheum 2005, 52:2506-2512.
40. Van Tubergen A., Debats I., Ryser L. The use of numerical rating scale as an answer modality in ankylosing spondylitis specific questionnaires. Arthritis Care Res 2002, 47:242-248.
41. El Miedany Y., Youssef S., Mehanna A., et al. Defining Disease Status in Ankylosing Spondylitis: Validation and cross Cultural Adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing Spondylitis Global score (BASG). Clin Rheumatol 2008, 27:605-612.
42. Hernandez-Cruz B., Cardiel M.H. Intra-observer reliability of commonly used outcome measures in rheumatoid arthritis. Clin Exp Rheumatol 1998, 16:459-462.